Thyroid Remnant 131I Ablation for Papillary and Follicular Thyroid Carcinoma

甲状腺癌 医学 甲状腺 滤泡癌 乳头状癌 烧蚀 卵泡期 病理 内科学
作者
Ernest L. Mazzaferri
出处
期刊:Thyroid [Mary Ann Liebert, Inc.]
卷期号:7 (2): 265-271 被引量:215
标识
DOI:10.1089/thy.1997.7.265
摘要

Outcome was compared in 1,004 patients with differentiated thyroid carcinoma (DTC) who underwent thyroid remnant ablation with 131I (n = 151) or were either treated with thyroid hormone alone (755) or given no postoperative medical therapy (98). Median follow-up time was 18.7 years for patients treated with thyroid hormone alone, 21.3 years for those given no adjunctive medical therapy, and 14.7 years for those treated with thyroid remnant ablation. End points measured were cancer recurrence, development of distant metastases, and death due to thyroid carcinoma. Tumor recurrence was about threefold lower (p < 0.001) and fewer patients developed distant metastases (p < 0.002) after thyroid remnant ablation than after other forms of postoperative treatment, an effect observed only in patients with primary tumors > or = 1.5 cm in diameter. The doses of 131I were stratified into two groups: 29-50 mCi (mean 47 mCi) in 43% and 51-200 mCi (111 mCi) in 57% of patients. Both groups experienced similar recurrence rates (7% and 9%, respectively, p = 0.7). There were fewer cancer deaths after thyroid remnant ablation than after the other treatment strategies (p < 0.001), differences that occurred only in patients aged 40 years or older at the time of initial treatment and with primary tumors > or = 1.5 cm. The variables that influenced cancer recurrence in a Cox proportional hazards model were absence of cervical lymph node metastases (hazards ratio [HR] 0.8), tumor stage (HR 1.8), and treatment of the thyroid remnant (HR 0.9); those that independently affected cancer-specific death rates were age (HR 13.3), recurrence of cancer (16.6), time to treatment (HR 3.5), thyroid remnant ablation (HR 0.5), and tumor stage (HR 2.3). This study suggests that thyroid remnant ablation is effective in reducing recurrence of DTC in patients of all ages and reduces the risk of death from thyroid carcinoma in patients > age 40 at the time of diagnosis. These effects are not apparent in patients with isolated tumors < 1.5 cm that are not metastatic to regional lymph nodes or invading the thyroid capsule. The optimal dose of 131I necessary to achieve this effect remains uncertain.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YN3585发布了新的文献求助10
刚刚
zh123完成签到,获得积分10
2秒前
迷人的天抒应助yjihn采纳,获得10
2秒前
4秒前
顶刊收割机完成签到,获得积分10
4秒前
刘标发布了新的文献求助10
4秒前
小二郎应助meimale采纳,获得30
5秒前
清脆香萱完成签到,获得积分10
5秒前
dengdeng发布了新的文献求助10
6秒前
科研黑猫完成签到,获得积分10
6秒前
科研通AI2S应助忧心的不二采纳,获得10
8秒前
YooM发布了新的文献求助10
8秒前
juju发布了新的文献求助10
8秒前
丘比特应助科研通管家采纳,获得10
8秒前
Lucas应助科研通管家采纳,获得10
8秒前
YamDaamCaa应助科研通管家采纳,获得30
9秒前
胖虎应助科研通管家采纳,获得10
9秒前
Orange应助科研通管家采纳,获得10
9秒前
华仔应助科研通管家采纳,获得10
9秒前
斯文败类应助科研通管家采纳,获得10
9秒前
空域发布了新的文献求助10
9秒前
9秒前
9秒前
cqhecq完成签到,获得积分10
10秒前
smottom应助行7采纳,获得10
10秒前
乂氼完成签到,获得积分10
11秒前
大个应助纯真的鸿涛采纳,获得30
13秒前
早点毕业完成签到 ,获得积分10
13秒前
13秒前
空域完成签到,获得积分10
14秒前
14秒前
15秒前
阳佟听荷发布了新的文献求助10
15秒前
Shicheng完成签到,获得积分10
16秒前
星辰大海应助徐小采纳,获得20
18秒前
Ava应助lapidary采纳,获得10
19秒前
YooM发布了新的文献求助10
20秒前
聪慧小霜应助搞怪含巧采纳,获得10
20秒前
20秒前
LUAN完成签到,获得积分10
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969628
求助须知:如何正确求助?哪些是违规求助? 3514448
关于积分的说明 11174217
捐赠科研通 3249822
什么是DOI,文献DOI怎么找? 1795000
邀请新用户注册赠送积分活动 875537
科研通“疑难数据库(出版商)”最低求助积分说明 804856